6-8 | So called “key populations” such as sex workers and men who have sex with men have both a higher risk of contracting HIV (*1) and a lower access to antiretroviral care due to stigma and discrimination as well as, in many instances, their illegal status and high mobility. New medications to prevent HIV negative people from contracting the virus (Pre-Exposure Prophylaxis, or PreP) are a promising tool to curtail the progression of the HIV pandemic, but access remains limited in the most affected areas of Southern Africa.
MSF launches challenge to Pfizer’s patent on the pneumonia vaccine in India, to increase access to more affordable versions
3-11 | Médecins Sans Frontières/Doctors Without Borders (MSF) has filed a ‘patent opposition’ in India to prevent US pharmaceutical company Pfizer from getting a patent on the pneumococcal conjugate vaccine (PCV13), so more affordable versions can become available to developing countries and humanitarian organisations.
8-20 | Two weeks after severe flooding affected an estimated one million people across Myanmar, Médecins Sans Frontières / Doctors Without Borders (MSF) is expanding its support to the government’s response in both Rakhine State and Sagaing Region. This will both help meet the immediate needs of those directly affected by flooding, and mitigate the elevated risk facing communities from water- and mosquito-borne infectious diseases, including malaria, diarrhoea, and dengue fever. Dengue fever is endemic to Rakhine state and Sagaing regio
8-5 | After days of severe rains across swathes of Myanmar in the wake of Cyclone Komen, Doctors Without Borders / Médecins Sans Frontières (MSF) is working with local government authorities to provide medical and non-medical aid to thousands of people affected by flooding. Rakhine State, where MSF already runs several medical programmes, is one of the most critically impacted areas.
3-25 | Indian generic companies should reject Gilead’s controversial hepatitis C programmeProgramme could compromise patient treatment and privacy rights Ahead of a meeting in Jaipur, India this week between US pharmaceutical company Gilead Sciences and several Indian companies which have entered into an agreement with Gilead to produce hepatitis C drugs, Médecins Sans Frontières/Doctors Without Borders (MSF) urged the generic companies to reject a high